- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Herpes zoster virus
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 549KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 70KB)
Varicella zoster virus recombinant vaccine – November 2023
Varicella Zoster Virus Recombinant Vaccine: Injection 1 vial & adjuvant substance diluent 0.5 mL vial; Shingrix®
Last updated
1 March 2024